Joan Puig de Dou
- Active in the pharmaceutical marketing for over 30 years
- President of CataloniaBIO&HealthTech
- CEO and Qualified Person at Kymos
- Leader of Kymos team, guaranteeing a trustable, ethical and scientific correct editorial publications.
Experience
Joan Puig de Dou started his career at Laboratorios Menarini first as scientist later as Qualified Person and finally as Operations General Manager. 2010 he entered Kymos where he became CEO in 2015. 2022 Joan Puig de Dou was elected as president of CataloniaBio&HealthTech to represent the Catalonian biotech industry nationally and internationally.
Expertise
Joan Puig de Dou has extensive experience in writing scientific content adopting a didactic approach that fits any reader’s level of expertise. He publishes regularely on Kymos’ webpage, social media and in the specialized press.
Education
He graduated from Universitat de Barcelona as Pharmacist and from IESE Business School’s Programa Diección General (PDG)
Want to know him better?
Read his interview in PharmaBoardrooom in January 2019 and more about his presidency of CataloniaBio at Parc Scíentific de Barcelona.
ICH M10 Comparison with EMA and FDA Past Guidelines on Bioanalytical Method Validation
Although the ICH has published recommendations for the validation of analytical methods used in the evaluation of the quality of drugs and active substances (ICH Q2) for more than 25 years, it was not until (...) Read more
Kymos and Prolytic are CIR certified
In addition to Kymos, which has been CIR certified for quite some time, our German subsidiary Prolytic has been approved a CIR certification as well. Now your R&D activities (from Early Phase up to Phase (...) Read more
Bioequivalence studies in Europe
Bioequivalence studies are designed to show that two drugs are equivalent and substitutable. - But even though the medicines are replaceable, the providers of bioequivalence studies are not. Digna Tost, Department Manager of Bioanalysis (...) Read more
DG-GT Meeting: Dresden, DE | 10-11 Mar 2025
BIO CHINA 2025: Suzhou, CHN | 13-15 Mar 2025
BIO-Europe Spring: Milan, IT | 25-26 Mar 2025
German Pharm-Tox Summit: Hannover, DE | 25-28 Mar 2025
German Biotech Days: Heidelberg, DE | 09-10 Apr 2025
MEET2WIN: Bourdeaux, FR | 06-07 May 2025
BIO KOREA 2025: Seoul, KR | 07-09 May 2025
BIONNALE 2025: Berlin, DE | 14-15 May 2025
Innovation for Cell and Gene Therapies (ICGT): Paris, FR | 22 May 2025
MabDesign Partnering Day: Lyon, FR | 02 Jun 2025
Congrès Polepharma Biotesting: Evreux, FR | 04-05 Jun 2025
International Oligonucleotides and Peptides Conference: Prague, CZ | 09-11 Jun 2025
AFI Simposio: Rimini, IT | 11-13 Jun 2025
Antibody Industrial Symposium (AIS): Tours, FR | 25-26 Jun 2025
CPHI 2025: Frankfurt, DE | 28-30 Oct 2025
